Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.
about
Suppression of chronic lymphocytic leukemia progression by CXCR4 inhibitor WZ811.Serum SDF-1 levels are a reliable diagnostic marker of feline mammary carcinoma, discriminating HER2-overexpressing tumors from other subtypes.Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4.Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
P2860
Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.
@en
type
label
Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.
@en
prefLabel
Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.
@en
P2093
P2860
P1476
Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.
@en
P2093
P2860
P2888
P356
10.1007/S40495-015-0044-8
P577
2016-01-04T00:00:00Z
P5875
P6179
1044390325